ID18095A - Turunan tetrahidrokinolin - Google Patents

Turunan tetrahidrokinolin

Info

Publication number
ID18095A
ID18095A IDP972834A ID972834A ID18095A ID 18095 A ID18095 A ID 18095A ID P972834 A IDP972834 A ID P972834A ID 972834 A ID972834 A ID 972834A ID 18095 A ID18095 A ID 18095A
Authority
ID
Indonesia
Prior art keywords
tetrahidrokinolin
tetrahidrokinolin down
Prior art date
Application number
IDP972834A
Other languages
English (en)
Indonesian (id)
Inventor
Romano Di-Fabio
Alessandra Pasquarello
Fabio Maria Sabbatini
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of ID18095A publication Critical patent/ID18095A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDP972834A 1996-08-17 1997-08-14 Turunan tetrahidrokinolin ID18095A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9617305.9A GB9617305D0 (en) 1996-08-17 1996-08-17 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ID18095A true ID18095A (id) 1998-02-26

Family

ID=10798623

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972834A ID18095A (id) 1996-08-17 1997-08-14 Turunan tetrahidrokinolin

Country Status (34)

Country Link
US (1) US6479488B1 (is)
EP (1) EP0922034B1 (is)
JP (1) JP4108129B2 (is)
KR (1) KR100552864B1 (is)
CN (1) CN1131214C (is)
AP (1) AP877A (is)
AR (1) AR008296A1 (is)
AT (1) ATE221052T1 (is)
AU (1) AU724473B2 (is)
BR (1) BR9711311B1 (is)
CA (1) CA2264118C (is)
CO (1) CO4900066A1 (is)
CZ (1) CZ296250B6 (is)
DE (1) DE69714265T2 (is)
DK (1) DK0922034T3 (is)
EA (1) EA001704B1 (is)
ES (1) ES2181030T3 (is)
GB (1) GB9617305D0 (is)
HU (1) HU225797B1 (is)
ID (1) ID18095A (is)
IL (1) IL128141A0 (is)
IS (1) IS4953A (is)
MY (1) MY116952A (is)
NO (1) NO312241B1 (is)
NZ (1) NZ333812A (is)
PE (1) PE107098A1 (is)
PL (1) PL194532B1 (is)
PT (1) PT922034E (is)
SI (1) SI0922034T1 (is)
TR (1) TR199900336T2 (is)
TW (1) TW449582B (is)
WO (1) WO1998007704A1 (is)
YU (1) YU6799A (is)
ZA (1) ZA977326B (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706294D0 (en) * 1997-03-26 1997-05-14 Glaxo Wellcome Spa Heterocyclic compound
MY125037A (en) 1998-06-10 2006-07-31 Glaxo Wellcome Spa 1,2,3,4 tetrahydroquinoline derivatives
US6455734B1 (en) 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
GB9929037D0 (en) * 1999-12-08 2000-02-02 Glaxo Wellcome Spa Heterocyclic derivatives
DE10132725A1 (de) 2001-07-05 2006-08-03 Grünenthal GmbH Substituierte γ-Lactonverbindungen
CN100402032C (zh) * 2001-12-28 2008-07-16 阿卡蒂亚药品公司 用作毒蕈碱激动剂的四氢喹啉类似物
BRPI0406592A (pt) * 2003-01-23 2005-12-20 Acadia Pharm Inc Usos de n-desmetilclozapina, métodos para o tratamento de psicose, de distúrbios afetivos, de demência, de dor neuropática e de glaucoma e composição farmacêutica
US20050250767A1 (en) * 2003-01-23 2005-11-10 Weiner David M Use of N-desmethylclozapine to treat human neuropsychiatric disease
US20050085463A1 (en) * 2003-01-23 2005-04-21 Weiner David M. Use of N-desmethylclozapine to treat human neuropsychiatric disease
US20060233843A1 (en) * 2003-02-19 2006-10-19 Conn P J Treatment of psychosis with a muscarinic m1 receptor ectopic activator
US7550454B2 (en) * 2003-12-22 2009-06-23 Acadia Pharmaceuticals, Inc. Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
JP2007536216A (ja) * 2004-04-01 2007-12-13 アカディア ファーマシューティカルズ，インコーポレーテッド 固体ｎ−デスメチルクロザピンおよびその結晶形を合成および単離する方法
RU2451014C2 (ru) * 2005-07-22 2012-05-20 Мотида Фармасьютикал Ко., Лтд. Новое производное гетероциклиден ацетамида
BRPI0613771B1 (pt) * 2005-07-22 2021-11-23 Mochida Pharmaceutical Co., Ltd Composto derivado de heterociclideno acetamida, composição farmacêutica e antagonista de receptor de tipo i vaniloide com potencial de receptor transitório (trpv1)
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
EP2324838A1 (en) * 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Compositions Comprising Dimethyl Sulfoxide (DMSO)
US7955418B2 (en) 2005-09-12 2011-06-07 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
US20070105836A1 (en) * 2005-10-31 2007-05-10 Lars Pettersson Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
US9855212B2 (en) 2009-10-30 2018-01-02 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
CA2850707C (en) 2011-10-03 2023-03-21 The University Of Utah Research Foundation Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL93610A0 (en) 1989-03-08 1990-12-23 Merck Sharp & Dohme Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them
WO1997012870A1 (en) * 1995-09-29 1997-04-10 Glaxo Wellcome S.P.A. Tetrahydroquinolines as nmda antagonists

Also Published As

Publication number Publication date
CZ52999A3 (cs) 1999-07-14
IS4953A (is) 1999-01-22
CN1131214C (zh) 2003-12-17
DE69714265D1 (de) 2002-08-29
PL331562A1 (en) 1999-07-19
EP0922034A1 (en) 1999-06-16
NO990723L (no) 1999-04-14
KR100552864B1 (ko) 2006-02-20
MY116952A (en) 2004-04-30
JP2001508031A (ja) 2001-06-19
US6479488B1 (en) 2002-11-12
PE107098A1 (es) 1999-01-15
TR199900336T2 (xx) 1999-04-21
ATE221052T1 (de) 2002-08-15
NO312241B1 (no) 2002-04-15
PL194532B1 (pl) 2007-06-29
AP877A (en) 2000-09-27
AU4551897A (en) 1998-03-06
CZ296250B6 (cs) 2006-02-15
CA2264118A1 (en) 1998-02-26
ZA977326B (en) 1999-02-15
NZ333812A (en) 2000-07-28
WO1998007704A1 (en) 1998-02-26
AR008296A1 (es) 1999-12-29
DK0922034T3 (da) 2002-11-18
EP0922034B1 (en) 2002-07-24
AP9901459A0 (en) 1999-03-31
CA2264118C (en) 2008-06-17
BR9711311B1 (pt) 2009-01-13
HUP9903108A3 (en) 2004-04-28
GB9617305D0 (en) 1996-09-25
KR20000068172A (ko) 2000-11-25
NO990723D0 (no) 1999-02-16
SI0922034T1 (en) 2003-02-28
HU225797B1 (en) 2007-09-28
ES2181030T3 (es) 2003-02-16
TW449582B (en) 2001-08-11
CO4900066A1 (es) 2000-03-27
EA001704B1 (ru) 2001-06-25
JP4108129B2 (ja) 2008-06-25
DE69714265T2 (de) 2003-03-06
PT922034E (pt) 2002-12-31
BR9711311A (pt) 1999-08-17
CN1227544A (zh) 1999-09-01
IL128141A0 (en) 1999-11-30
YU6799A (sh) 2000-03-21
EA199900121A1 (ru) 1999-10-28
AU724473B2 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
DE69705189T2 (de) Rasierhobelhandgriff
BR9703884A (pt) Cicloalcanopiridinas
BR9704464A (pt) Evisceradora
ID19474A (id) Turunan tiazola
ATE262512T1 (de) Arylalkanoylpyridazine
BR9707851A (pt) Quinoxalinodionas
ID18095A (id) Turunan tetrahidrokinolin
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
BR9703563A (pt) Hidromancal
BR9703835A (pt) Hidromancal
BR9707467A (pt) 1-Pirazol-3-iletil-4-indol-3-ilpiperdinas
BR9708716A (pt) 3-cianoaril-pirazóis
DE29602607U1 (de) Bitbox
DE69711532D1 (de) Lithiumborosilikatphosphor
BR9603975A (pt) Fix-catch
BR9600112A (pt) Conaço
SE9601101D0 (sv) Watcheye
BR9605291A (pt) Hidro-coleta
BR9604479A (pt) Gongorremo
BR9604349A (pt) Xapisqueira
BR9603978A (pt) Confort-let
BR9603977A (pt) Fix-ped
BR9603976A (pt) Stop-entope
BR9606252A (pt) Cromosauna
BR9603887A (pt) Fix-imobi